1. P422 Transition from intravenous to subcutaneous infliximab and vedolizumab: adherence, satisfaction and safety profile in a cohort of patients with Inflammatory Bowel Disease. (30th January 2023) Authors: Todeschini, A; Geccherle, A; Signoretto, P; Fasoli, E; Variola, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P626 Safety of recombinant zoster vaccine in patients with Inflammatory Bowel Disease: a single centre experience. (30th January 2023) Authors: Todeschini, A; Geccherle, A; Signoretto, P; Variola, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗